Position in LLY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$83,103,713
+$12,988,727 QoQ
Shares Held
69,286
-9.1% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
2.76%
of 13F equity value
Holder Rank
#417
of 4,605 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 84%
Shared 0%
None 16%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON CAPITAL MANAGEMENT LLC holds $189,707,778 across 12 Drug Manufacturers - General names. LLY ranks #1 (43.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
69,286 | $83,103,713 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
411,727 | $52,017,589 | |
| 3 | AZN |
Astrazeneca PLC
|
201,189 | $38,149,458 | |
| 4 | JNJ |
Johnson & Johnson
|
21,048 | $5,345,560 | |
| 5 | MRK |
Merck & Co., Inc.
|
29,329 | $3,768,776 | |
| 6 | ABBV |
AbbVie Inc.
|
13,608 | $3,424,317 | |
| 7 | AMGN |
Amgen Inc
|
4,095 | $1,482,881 | |
| 8 | NVS |
Novartis AG
|
7,290 | $1,142,488 |
All Filings in LLY
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $83,103,713 | 69,286 | Shares | Sole | 2026-08-04 | |
| 2026-03-31 | $70,114,986 | 76,231 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $72,143,275 | 67,130 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $50,394,624 | 66,048 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $69,909,809 | 89,682 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $57,343,757 | 69,431 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $54,483,128 | 70,574 | Shares | Sole | 2025-02-07 | |
| 2024-09-30 | $43,458,900 | 49,054 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $14,159,237 | 15,639 | Shares | Sole | 2024-08-01 | |
| 2024-03-31 | $12,183,631 | 15,661 | Shares | Sole | 2024-05-07 | |
| 2023-12-31 | $9,112,205 | 15,632 | Shares | Sole | 2024-01-18 | |
| 2023-09-30 | $8,396,953 | 15,633 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $7,331,095 | 15,632 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $5,368,341 | 15,632 | Shares | Sole | 2023-05-16 | |
| 2022-12-31 | $5,718,810 | 15,632 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $5,054,607 | 15,632 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $5,068,363 | 15,632 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $4,476,535 | 15,632 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $4,317,871 | 15,632 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $3,611,773 | 15,632 | Shares | Sole | 2021-11-04 | |
| 2021-06-30 | $3,587,856 | 15,632 | Shares | Sole | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||